Market Overview:
The global MALDI-TOF automatic mass spectrometry market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for MALDI-TOF technology from biopharmaceuticals companies, research institutions, and others. Additionally, the growing adoption of MALDI-TOF technology in proteomics and other applications is also contributing to the growth of this market. However, factors such as high cost of instruments and limited availability of skilled professionals are restraining the growth of this market.
Product Definition:
MALDI-TOF Automatic Mass Spectrometry is a technique used to identify and characterize proteins and other biomolecules. It is important because it can identify proteins down to the level of a single molecule, which can help researchers understand the function and structure of proteins.
Below 2000FWHM:
The below 2000FWHM market is expected to grow at a CAGR of XX% from 2016 to 2024. The growth can be attributed to the increasing demand for mass spectrometry in research and development activities, drug discovery processes, proteomics studies as well as other applications such as food testing &quality control.
Increasing R&D investments by biotechnology companies are also one of the key factors driving the below 2000FWHM market growth.
2000-5000FWHM:
2000-5000FWHM is the size of the smallest particle that can be detected by MALDI-TOF MS. It is a measure of how much light (photons) will strike a given area of a test sample and cause ionization to occur. The higher the value, the better is mass resolution and sensitivity for detecting smaller particles such as viruses, bacteria or molecules.
Application Insights:
The others application segment dominated the global market in 2017, accounting for a share of over 40.0% and is expected to continue its dominance over the forecast period. The growth can be attributed to extensive usage across various research applications including proteomics, metabolomics and drug discovery & development.
The biopharmaceutical companies are also anticipated to contribute significantly towards industry growth during the forecast period owing to increasing R&D activities at pharmaceutical companies globally coupled with an increase in focus on personalized medicine through targeted drugs. This has resulted in increased demand for highly sensitive techniques that help analyze complex samples with ease while identifying specific target molecules within them. MALDI-TOF offers all these advantages making it suitable for use across various research applications within biopharmaceutical industries worldwide.
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a large number of biopharmaceutical companies and research institutes involved in drug discovery activities. Moreover, these players are investing huge amounts for R&D activities related to new drugs development, which is expected to drive the regional market further. Asia Pacific region is anticipated to grow at a lucrative CAGR over the forecast period owing to increasing government funding for life science research and higher healthcare spending by consumers due to rising disease prevalence rates in this region.
The European market also held a significant share of global revenue in 2017 due its involvement with MALDI-TOF mass spectrometry instruments through collaborative programs with national laboratories across Europe that support instrument distribution as well as training sessions on how best use these instruments for various applications within an organization or laboratory environment (Kumar & Sarma, 2016).
Growth Factors:
- Increasing demand for rapid and accurate diagnosis of diseases
- Rising prevalence of target diseases
- Technological advancements in MALDI-TOF Automatic Mass Spectrometry systems
- Growing number of collaborations and partnerships between diagnostic companies and research institutes for development of new applications for MALDI-TOF Automatic Mass Spectrometry technology
- Increasing investments by private equity firms in the diagnostics sector
Scope Of The Report
Report Attributes
Report Details
Report Title
MALDI-TOF Automatic Mass Spectrometry Market Research Report
By Type
Below 2000FWHM, 2000-5000FWHM, Above 5000FWHM
By Application
Biopharmaceuticals Companies, Research Institutions, Others
By Companies
Shimadzu, Bruker, JEOL, Waters, SCIEX, Zhuhai Meihua Medical Technology Ltd., ICLEAR
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global MALDI-TOF Automatic Mass Spectrometry Market Report Segments:
The global MALDI-TOF Automatic Mass Spectrometry market is segmented on the basis of:
Types
Below 2000FWHM, 2000-5000FWHM, Above 5000FWHM
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceuticals Companies, Research Institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shimadzu
- Bruker
- JEOL
- Waters
- SCIEX
- Zhuhai Meihua Medical Technology Ltd.
- ICLEAR
Highlights of The MALDI-TOF Automatic Mass Spectrometry Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Below 2000FWHM
- 2000-5000FWHM
- Above 5000FWHM
- By Application:
- Biopharmaceuticals Companies
- Research Institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the MALDI-TOF Automatic Mass Spectrometry Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MALDI-TOF is an automated mass spectrometry technique that uses a laser to vaporize the sample and then ionize the molecules in the vaporized sample. The ions are then accelerated through a magnetic field and fired at a target, which breaks down the ions into their component atoms. This process can be repeated multiple times to generate a spectrum of all of the atoms in the sample.
Some of the major players in the maldi-tof automatic mass spectrometry market are Shimadzu, Bruker, JEOL, Waters, SCIEX, Zhuhai Meihua Medical Technology Ltd., ICLEAR.
The maldi-tof automatic mass spectrometry market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 MALDI-TOF Automatic Mass Spectrometry Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 MALDI-TOF Automatic Mass Spectrometry Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 MALDI-TOF Automatic Mass Spectrometry Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the MALDI-TOF Automatic Mass Spectrometry Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global MALDI-TOF Automatic Mass Spectrometry Market Size & Forecast, 2020-2028 4.5.1 MALDI-TOF Automatic Mass Spectrometry Market Size and Y-o-Y Growth 4.5.2 MALDI-TOF Automatic Mass Spectrometry Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Below 2000FWHM
5.2.2 2000-5000FWHM
5.2.3 Above 5000FWHM
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Biopharmaceuticals Companies
6.2.2 Research Institutions
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global MALDI-TOF Automatic Mass Spectrometry Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 MALDI-TOF Automatic Mass Spectrometry Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Below 2000FWHM
9.6.2 2000-5000FWHM
9.6.3 Above 5000FWHM
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Biopharmaceuticals Companies
9.10.2 Research Institutions
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Below 2000FWHM
10.6.2 2000-5000FWHM
10.6.3 Above 5000FWHM
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Biopharmaceuticals Companies
10.10.2 Research Institutions
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Below 2000FWHM
11.6.2 2000-5000FWHM
11.6.3 Above 5000FWHM
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Biopharmaceuticals Companies
11.10.2 Research Institutions
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Below 2000FWHM
12.6.2 2000-5000FWHM
12.6.3 Above 5000FWHM
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Biopharmaceuticals Companies
12.10.2 Research Institutions
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Below 2000FWHM
13.6.2 2000-5000FWHM
13.6.3 Above 5000FWHM
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Biopharmaceuticals Companies
13.10.2 Research Institutions
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 MALDI-TOF Automatic Mass Spectrometry Market: Competitive Dashboard
14.2 Global MALDI-TOF Automatic Mass Spectrometry Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Shimadzu
14.3.2 Bruker
14.3.3 JEOL
14.3.4 Waters
14.3.5 SCIEX
14.3.6 Zhuhai Meihua Medical Technology Ltd.
14.3.7 ICLEAR